Mid term effects of pulmonary thromboendarterectomy on clinical and cardiopulmonary function status

Zoia, M. C; D'Armini, A. M.; Beccaria, M.; Corsico, A.; Fulgoni, P.; Klersy, C.; Piovella, F.; Viganà, M.; Cerveri, I.
July 2002
Thorax;Jul2002, Vol. 57 Issue 7, p608
Academic Journal
Background: Chronic thromboembolic pulmonary hypertension (CTEPH) can be successfully treated surgically by pulmonary thromboendarterectomy (PTE) but there are few data on mid-term cardiopulmonary function, particularly on exertion, and clinical benefits following pulmonary PTE. Methods: A 2 year follow up study was undertaken of clinical status, haemodynamic and lung function indices, gas exchange, and exercise tolerance in 38 patients of mean (SD) age 50 (15) years who had undergone PTE. Results: In-hospital mortality was about 10%. Before PTE all the patients were severely impaired (NYHA classes III-IV). There was no time difference in the improvement in the parameters: nearly all the improvement in cardiac output, gas exchange, and clinical status was achieved in the first 3 months as a result of the relief of pulmonary obstruction. At 3 months the percentage of patients with normal cardiac output and Pao2 and of those with reduced clinical impairment increased to 97%, 59%, and 87%, respectively, without any further change. Only mean pulmonary artery pressure (mPAP), carbon monoxide transfer factor (TLCO), and exercise tolerance improved gradually during the second year, probably due to the recovery of the damaged small vessels. TLCO was overestimated before PIE but afterwards the trend was similar to that of mPAP. Conclusions: At mid term only a few patients did not have a satisfactory recovery because of lack of operative success, hypertension relapse, or the effect of preoperative hypertension on vessels in non- obstructed segments. Most of the patients, even the more compromised ones, had excellent long lasting results.


Related Articles

  • Peripheral airway obstruction in primary pulmonary hypertension. Meyer, F. J.; Ewert, R.; Hoeper, M. M.; Olschewski, H.; Behr, J.; Winkler, J.; Wilkens, H.; Breuer, C.; Kübler, W.; Borst, M. M. // Thorax;Jun2002, Vol. 57 Issue 6, p473 

    Background: As there is controversy about changes in lung function in primary pulmonary hypertension (PPH), lung mechanics were assessed with a focus on expiratory airflow in relation to pulmonary haemodynamics Methods: A cross sectional study was performed in 64 controls and 171 patients with...

  • Comparison of Non-invasive Methods - Impedance Cardiography and 2-dimentional Transthoracic Echocardiography Applied for Diagnostics of Pulmonary Artery Hypertension.  // Electronics & Electrical Engineering;2010, Issue 105, p105 

    No abstract available.

  • Pulmonary Arterial Enlargement and Acute Exacerbations of COPD. Wells, J. Michael; Washko, George R.; Han, Meilan K.; Abbas, Naseer; Nath, Hrudaya; Mamary, A. James; Regan, Elizabeth; Bailey, William C.; Martinez, Fernando J.; Westfall, Elizabeth; Beaty, Terri H.; Curran.-Everett, Douglas; Curtis, Jeffrey L.; Hokanson, John E.; Lynch, David A.; Make, Barry J.; Crapo, James D.; Silverman, Edwin K.; Bowler, Russell P.; Dransfield, Mark T. // New England Journal of Medicine;9/6/2012, Vol. 367 Issue 10, p913 

    Background: Exacerbations of chronic obstructive pulmonary disease (COPD) are associated with accelerated loss of lung function and death. Identification of patients at risk for these events, particularly those requiring hospitalization, is of major importance. Severe pulmonary hypertension is...

  • Restrictive Ventilatory Impairment and Arterial Oxygenation Characterize Rest and Exercise Ventilation in Patients After Fontan Operation. Ohuchi, H.; Ohashi, H.; Takasugi, H.; Yamada, O.; Yagiharar, T.; Echigo, S. // Pediatric Cardiology;Sep/Oct2004, Vol. 25 Issue 5, p513 

    The objective of this study was evaluate the relationships between abnormal pulmonary circulation, lung function, and respiratory response during exercise in Fontan patients. Pulmonary function and cardiopulmonary exercise tests were performed in 101 Fontan patients and 122 controls. A small...

  • Clinical Worsening During Long-Term Follow-Up in Inoperable Chronic Thromboembolic Pulmonary Hypertension. Scholzel, Bastiaan; Post, Martijn; Thijs Plokker, H.; Snijder, Repke // Lung;Apr2012, Vol. 190 Issue 2, p161 

    Background: Pulmonary endarterectomy is the treatment of choice in chronic thromboembolic pulmonary hypertension (CTEPH). Modern pulmonary vasoactive medication (like endothelin receptor antagonists, phosphodiesterase type 5 inhibitors, and prostacyclins) is used in patients with an inoperable...

  • MicroRNAs-control of essential genes: Implications for pulmonary vascular disease. Joshi, Sachindra R.; McLendon, Jared M.; Comer, Brian S.; Gerthoffer, William T. // Pulmonary Circulation;2011, Vol. 1 Issue 3, p357 

    During normal lung development and in lung diseases structural cells in the lungs adapt to permit changes in lung function. Fibroblasts, myofibroblasts, smooth muscle, epithelial cells, and various progenitor cells can all undergo phenotypic modulation. In the pulmonary vasculature occlusive...

  • Tissue Doppler Evaluation of Tricuspid Annulus for Estimation of Pulmonary Artery Pressure in Patients with COPD. Melek, Mehmet; Esen, Ozlem; Esen, Ali; Barutcu, Irfan; Fidan, Fatma; Onrat, Ersel; Kaya, Dayimi // Lung;May/Jun2006, Vol. 184 Issue 3, p121 

    Because transthoracic echocardiography is an inexpensive, easy, and reproducible method, it is the most commonly used noninvasive diagnostic tool to determine pulmonary artery pressure (PAP). Tissue Doppler imaging (TDI) emerged as a new echocardiographic method that can be applied in various...

  • Conventional and targeted medical therapies. Barst, Robyn J.; Stewart, Duncan // Cardiology in the Young;May2009, Vol. 19 Issue S1, p28 

    The article offers information on the conventional medical therapy to patient with pulmonary hypertension, a progressive disease which is also defined as pulmonary vascular obstructive disease. It notes that patient with pulmonary arterial hypertension is advised to maintain physical activities...

  • Pulmonary hypertension: Past, present and future. Barst, Robyn J. // Annals of Thoracic Medicine;Jan-Mar2008, Vol. 3 Issue 1, p1 

    The article discusses pulmonary arterial hypertension (PAH). It describes PAH as a progressive disease characterized by an elevation of pulmonary artery pressure and pulmonary vascular resistance. It recalls a study in which the use of tolzoline in a young woman with idiopathic PAH (IPAH) caused...


Read the Article


Sign out of this library

Other Topics